Is cytology reliable for epidermal growth factor receptor gene evaluation in non-small cell lung cancer?

Journal of Thoracic Oncology

Volumn 5, Issue 4, 2010, Pages 551-553

  Bozzetti, Cecilia ^a   Tiseo, Marcello ^a   Lagrasta, Costanza ^a   Nizzoli, Rita ^a   Guazzi, Annamaria ^a   Graiani, Gallia ^a   Rindi, Guido ^a   Ardizzoni, Andrea ^a  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;

ARTICLE; CLINICAL ARTICLE; CYTOLOGY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; RELIABILITY;

EID: 77951010280     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181ce3b28     Document Type: Article

References (14)

1. Bunn PA Jr, Franklin WA. Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer. Semin Oncol 2002;29(Suppl 14):38-44.
2. Giaccone G. Epidermal growth factor receptor inhibitors in the treatment of non-small cell lung cancer. J Clin Oncol 2005;23:3235-3242. (Pubitemid 46211348)
3. Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med 2008;358:1160-1174.
4. Bunn PA Jr, Dziadziuszko R, Varella-Garcia M, et al. Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy. Clin Cancer Res 2006;12:3652-3656. (Pubitemid 44000246)
5. Cappuzzo F, Hirsch FR, Rossi E, et al. Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small cell lung cancer. J Natl Cancer Inst 2005;97:643-655. (Pubitemid 40812628)
6. Hirsch FR, Varella-Garcia M, Bunn PA Jr, et al. Molecular predictors of outcome with gefitinib in phase III placebo-controlled study in advanced non-small-cell lung cancer. J Clin Oncol 2006;24:5034-5042. (Pubitemid 46631407)
7. Zhu CQ, Da Cunha Santos G, Ding K, et al. Role of K-ras and EGFR as biomarkers of response to Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21. J Clin Oncol 2008;26:4268-4275. (Pubitemid 351787301)
8. Bozzetti C, Tiseo M, Lagrasta C, et al. Comparison between epidermal growth factor receptor (EGFR) gene expression in primary non-small cell lung cancer (NSCLC) and in fine-needle aspirates from distant metastatic sites. J Thorac Oncol 2008;3:18-22.
9. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med 2008;359:1367-1368.
10. Cappuzzo F. EGFR FISH versus mutation: different tests, different end-points. Lung Cancer 2008;60:160-165.
11. Savic S, Tapia C, Grilli B, et al. Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small cell lung cancer. Br J Cancer 2008;98:154-160.
12. Franklin WA, Veve R, Hirsch FR, et al. Epidermal growth factor receptor family in lung cancer and premalignancy. Semin Oncol 2002;29:3-14. (Pubitemid 34226514)
13. Kurie JM, Shin HJ, Lee JS, et al. Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium. Clin Cancer Res 1996;2:1787-1793. (Pubitemid 26356366)
14. Piyathilake CJ, Frost AR, Manne U, et al. Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung. Clin Cancer Res 2002;8:734-744. (Pubitemid 34742102)